100 related articles for article (PubMed ID: 32900621)
1. Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response.
Ghodoussipour S; Xu W; Tran K; Atkinson R; Cho D; Miranda G; Cai J; Bhanvadia S; Schuckman A; Daneshmand S; Djaladat H
Urol Oncol; 2021 Feb; 39(2):133.e1-133.e8. PubMed ID: 32900621
[TBL] [Abstract][Full Text] [Related]
2. Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.
Kaag MG; Milowsky MI; Dalbagni G; Thompson RH; Katz D; Reuter VE; Herr HW; Bajorin D; Bochner BH
BJU Int; 2011 Oct; 108(8 Pt 2):E272-7. PubMed ID: 21320277
[TBL] [Abstract][Full Text] [Related]
3. Using machine learning to develop preoperative model for lymph node metastasis in patients with bladder urothelial carcinoma.
Ji J; Zhang T; Zhu L; Yao Y; Mei J; Sun L; Zhang G
BMC Cancer; 2024 Jun; 24(1):725. PubMed ID: 38872141
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
Rahman SN; Lokeshwar SD; Syed JS; Javier-Desloges JF; Press BH; Choksi AU; Rajwa P; Pradere B; Ploussard G; Kim JW; Monaghan TF; Renzulli JR; Shariat SF; Leapman MS
Urol Oncol; 2023 Feb; 41(2):107.e1-107.e8. PubMed ID: 36481253
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S
Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186
[TBL] [Abstract][Full Text] [Related]
6. The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
von Deimling M; Mertens LS; Furrer M; Li R; Tendijck GAH; Taylor J; Crocetto F; Maas M; Mari A; Pichler R; Moschini M; Tully KH; D'Andrea D; Laukhtina E; Del Giudice F; Marcq G; Velev M; Gallioli A; Albisinni S; Mori K; Khanna A; Rink M; Fisch M; Minervini A; Black PC; Lotan Y; Spiess PE; Kiss B; Shariat SF; Pradere B;
BJU Int; 2024 Jul; 134(1):119-127. PubMed ID: 38470089
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
Grobet-Jeandin E; Lenfant L; Pinar U; Parra J; Mozer P; Renard-Penna R; Thibault C; Rouprêt M; Seisen T
Nat Rev Urol; 2024 Jun; 21(6):339-356. PubMed ID: 38297079
[TBL] [Abstract][Full Text] [Related]
8. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J; Max Bruins H; Carrión A; Cathomas R; Compérat E; Efstathiou JA; Fietkau R; Gakis G; Lorch A; Martini A; Mertens LS; Meijer RP; Milowsky MI; Neuzillet Y; Panebianco V; Redlef J; Rink M; Rouanne M; Thalmann GN; Sæbjørnsen S; Veskimäe E; van der Heijden AG
Eur Urol; 2024 Jan; 85(1):17-31. PubMed ID: 37858453
[TBL] [Abstract][Full Text] [Related]
9. Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer.
Antar RM; Xu VE; Adesanya O; Drouaud A; Longton N; Gordon O; Youssef K; Kfouri J; Azari S; Tafuri S; Goddard B; Whalen MJ
Curr Oncol; 2024 May; 31(5):2566-2581. PubMed ID: 38785473
[No Abstract] [Full Text] [Related]
10. Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives.
Dłubak A; Karwacki J; Logoń K; Tomecka P; Brawańska K; Krajewski W; Szydełko T; Małkiewicz B
Curr Oncol Rep; 2023 Nov; 25(11):1327-1344. PubMed ID: 37801187
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts.
Jaganmurugan R; Arora A; Chandankhede U; Prakash G; Bakshi G; Joshi A; Menon S; Murthy V; Pal M
Clin Genitourin Cancer; 2024 Apr; 22(2):385-393. PubMed ID: 38245435
[TBL] [Abstract][Full Text] [Related]
12. Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.
Hadjiiski L; Weizer AZ; Alva A; Caoili EM; Cohan RH; Cha K; Chan HP
AJR Am J Roentgenol; 2015 Aug; 205(2):348-52. PubMed ID: 26204286
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: its association with clinical characteristics and survival after cystectomy.
Homma I; Kitamura H; Torigoe T; Tanaka T; Sato E; Hirohashi Y; Masumori N; Sato N; Tsukamoto T
Cancer Sci; 2009 Dec; 100(12):2331-4. PubMed ID: 19751235
[TBL] [Abstract][Full Text] [Related]
14. Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.
Keegan KA; Zaid HB; Patel SG; Chang SS
Curr Urol Rep; 2014 Apr; 15(4):394. PubMed ID: 24566815
[TBL] [Abstract][Full Text] [Related]
15. The role of surgery for locally advanced urothelial cancers.
Ibilibor C; Kennady EH; Greene KL
Curr Opin Urol; 2022 Nov; 32(6):614-617. PubMed ID: 36081394
[TBL] [Abstract][Full Text] [Related]
16. SEOM clinical guidelines for the treatment of invasive bladder cancer.
Morales R; Font A; Carles J; Isla D
Clin Transl Oncol; 2011 Aug; 13(8):552-9. PubMed ID: 21821489
[TBL] [Abstract][Full Text] [Related]
17. Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
Patel SA; Liu Y; Solanki AA; Baumann BC; Efstathiou JA; Jani AB; Chang AJ; Fischer-Valuck B; Royce TJ
Urol Oncol; 2023 Jul; 41(7):325.e15-325.e23. PubMed ID: 36725382
[TBL] [Abstract][Full Text] [Related]
18. A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.
Borregales LD; Venkat S; Posada Calderon L; Lewicki P; Flynn T; Faltas BM; Molina AM; Golombos DM; O'Malley P; Scherr DS
Eur Urol; 2023 Dec; 84(6):604-606. PubMed ID: 37353441
[No Abstract] [Full Text] [Related]
19. A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3).
Garg H; Bhandari M; Dursun F; Liss MA; Kaushik D; Svatek RS; Mansour AM
Front Oncol; 2023; 13():1157880. PubMed ID: 38273851
[TBL] [Abstract][Full Text] [Related]
20. Influence of Neoadjuvant Chemotherapy on Survival Outcomes of Radical Cystectomy in Pathologically Proven Positive and Negative Lymph Nodes.
Kaczmarek K; Małkiewicz B; Skonieczna-Żydecka K; Lemiński A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
